Pharma Giants Slide On Alzheimer’s Failures — Taking Biogen With Them

This post was originally published on this site

Shares of Eli Lilly (LLY) and Roche (RHHBY) slipped Monday after the pharmaceutical companies’ experimental Alzheimer’s treatments failed in lengthy tests. X. Error loading player: No playable sources found. In early trading on the stock market today, Lilly …

Click here to read full article